Skip to content
Technology Innovation

SLB Announces Dates for First-Quarter 2026 Results Conference Call

SLB 2 mins read
HOUSTON--BUSINESS WIRE--

SLB (NYSE:SLB) will hold a conference call on April 24, 2026, to discuss the results for the first quarter ending March 31, 2026.

The conference call is scheduled to begin at 11:00 a.m. US Eastern time and a press release regarding the results will be issued at 7:00 a.m. US Eastern time.

To access the conference call, listeners should contact the Conference Call Operator at +1 (833) 470-1428 within North America or +1 (404) 975-4839 outside of North America approximately 10 minutes prior to the start of the call and the access code is 742955.

A webcast of the conference call will be broadcast simultaneously at https://events.q4inc.com/attendee/972985185 on a listen-only basis. Listeners should log in 15 minutes prior to the start of the call to test their browsers and register for the webcast. Following the end of the conference call, a replay will be available at www.slb.com/irwebcast until May 1, 2026, and can be accessed by dialing +1 (866) 813-9403 within North America or +1 (929) 458-6194 outside of North America and giving the access code 360731.

About SLB

SLB (NYSE: SLB) is a global technology company that has driven energy innovation for 100 years. With a global footprint in more than 100 countries and employees representing almost twice as many nationalities, we work each day on innovating oil and gas, delivering digital at scale, decarbonizing industries, and developing and scaling new energy systems that accelerate the energy transition. Find out more at slb.com.


Contact details:

Investors
James R. McDonald – SVP of Investor Relations & Industry Affairs
Joy V. Domingo – Director of Investor Relations
SLB
Tel: +1 (713) 375-3535
[email protected]

Media
Josh Byerly – SVP of Communications
Moira Duff – Director of External Communications
SLB
Tel: +1 (713) 375-3407
[email protected]

Media

More from this category

  • Technology Innovation
  • 27/03/2026
  • 04:11
WP Engine

WP Engine Announces DE{CODE} 2026: Shape What’s Next

The seventh annual virtual conference explores the Intelligent Web, a new era of digital experiences serving both human and AI audiences AUSTIN, Texas–BUSINESS WIRE–…

  • Contains:
  • Technology Innovation
  • 26/03/2026
  • 23:56
Omdia

Omdia: YouTube Expected to Approach 3 Billion Global Users by 2027 as Netflix Surpasses 1 Billion

LONDON–BUSINESS WIRE– Netflix is forecast to reach over 1 billion monthly active users globally by 2027, while YouTube is expected to approach 3 billion…

  • Contains:
  • Technology Innovation
  • 26/03/2026
  • 23:40
Rubedo Life Sciences, Inc.

Rubedo Life Sciences Announces Positive Preliminary Phase 1 Clinical Trial Results for Lead Drug Candidate RLS-1496 in Patients with Plaque Psoriasis, Atopic Dermatitis, and Skin Aging

The Phase 1 study of RLS-1496, the first human trial of a GPX4 (selective glutathione peroxidase 4) modulator, met its primary endpoint and also demonstrated a statistically significant relationship between target engagement and clinical improvement in psoriasis and atopic dermatitis RLS-1496 is a first-in-class disease-modifying mechanism targeting pathological senescent cells that drive inflammaging and chronic degenerative diseases of aging A second study for RLS-1496 – a Phase 1b/2a study in actinic keratosis (precancerous skin lesions) – is underway in the United States, with completion expected later this year Rubedo CEO Frederick Beddingfield, III, MD, PhD, FAAD, to moderate panel on…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.